Coral Laboratories P/E Ratio
Current P/E Ratio
11.52
Low Valuation
Low - May indicate good value opportunity
Coral Laboratories (CORALAB) P/E ratio is 11.52 (Low), EPS (TTM) ₹67.61, current price ₹469.35 on BSE — Low - May indicate good value opportunity. For live price, revenue and the complete fundamental profile, see Coral Laboratories share price today.
Current Valuation Metrics
P/E Ratio
11.52
Current Price
₹469.35
EPS (TTM)
₹67.61
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
50.08
Sector Median
29.4
Sector Rank
#11 of 190
Sector Percentile
5.8%
CORALAB P/E Ratio — Valuation Signal & Historical Context
Coral Laboratories P/E 11.52 — signal: Undervalued. Browse CORALAB complete financial statements for revenue, profit, balance sheet and cash flow data.
- Stock appears undervalued with PE of 11.52, suggesting potential buying opportunity
- Trading at discount to sector average PE of 50.08
CORALAB vs Healthcare Peers — P/E Ratio Comparison
Coral Laboratories P/E 11.52 vs Healthcare average 50.08, median 29.4 — range 1.0–869.57.
Sector Average
50.08
Sector Median
29.4
Lowest P/E
1.0
Highest P/E
869.57
Companies
190
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.0 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹61 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |